Day: September 23, 2022

WINTER PARK, Fla., Sept. 23, 2022 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the third quarter 2022 after the market closes on Thursday, October 20, 2022. A conference call to discuss its financial and operating results is scheduled for Friday, October 21, 2022 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at www.alpinereit.com or at the link provided in the event details below. To access the call by phone, please go to the registration link provided in the event details below and you will be provided with dial-in details.Event Details:         Webcast:   https://edge.media-server.com/mmc/p/yi9b88dx  Registration:   https://register.vevent.com/register/BI9047aacc7c5140259934be90261b1e14We...

WINTER PARK, Fla., Sept. 23, 2022 (GLOBE NEWSWIRE) — CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the third quarter 2022 after the market closes on Thursday, October 27, 2022. A conference call to discuss its financial and operating results is scheduled for Friday, October 28, 2022 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at www.ctoreit.com or at the link provided in the event details below. To access the call by phone, please go to the registration link provided in the event details below and you will be provided with dial-in details.Event Details:     Webcast:  https://edge.media-server.com/mmc/p/haf26ajsRegistration: https://register.vevent.com/register/BI7d526face25a498fb3ea12784d73ae34We...

VEON Group CEO share award Increasing direct share ownership Amsterdam, 23 September 2022 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces a share award to Group CEO Kaan Terzioğlu. The award of 5,231,771 shares will be issued with a grant date of 1 October 2022. 1,569,531 shares will vest on the grant date of 1 October 2022 and the balance of 3,662,240 shares will vest on 1 September 2023. The total number of ADSs/common shares currently held by Kaan Terzioğlu is 1,674,900. Gunnar Holt, Chairman of the VEON Board of Directors, commented: “Kaan has shown extraordinary commitment, professionalism and sound judgement to help navigate VEON Group through the current challenging operating environment while continuing to execute on our digital...

Amryt Supports FH Awareness Day – September 24, 2022 DUBLIN, Ireland, and Boston MA, September 23, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, announces its support today for FH Awareness Day 2022 which will take place on Saturday, September 24, 2021. Dr Joe Wiley, CEO of Amryt Pharma, commented: “All of the Amryt team are pleased to support the great work of the Family Heart Foundation and FH Europe as they seek to raise awareness of this rare and devastating disease. Those with HoFH often go undiagnosed for years and raising awareness is critical to accurate and timely diagnosis that improves outcomes for patients. For our part at Amryt, we are collaborating with all stakeholders to continue to deliver...

NEW YORK and LEAMINGTON, Ontario, Sept. 23, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that the Company will release financial results for its first quarter fiscal 2023 ended August 31, 2022 on October 7, 2022 at 8:30 an Eastern Time. Live Audio Webcast: The Company will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray’s website at www.Tilray.com. A replay will be available and archived after the live webcast. Additionally, the live audio webcast will be syndicated on the www.Public.com investor app. Tilray Brands’ partnership...

ADDISON, Texas, Sept. 23, 2022 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the premier North American transportation solutions specialist dedicated to servicing challenging industrial end-markets, announced today that it had accepted the resignation of Executive Vice President and Chief Financial Officer (“CFO”) Jason Bates, effective September 19, 2022. Mr. Bates stepped down at this time as a result of familial obligations that necessitated a move away from the Dallas-Ft. Worth metro area, where Daseke, Inc. is headquartered. Mr. Bates’s resignation is not the result of any dispute or disagreement with the Company, including any matters relating to the Company’s accounting practices or financial reporting. About Daseke, Inc. Daseke, Inc. is the premier North American transportation solutions specialist...

WINNIPEG, Manitoba, Sept. 23, 2022 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce that it has placed 64th on the 2022 Report on Business ranking of Canada’s Top Growing Companies out of the 430 companies that participated. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Delta 9 Cannabis earned its spot with three-year revenue growth of 723%. Delta 9’s annual revenues have grown from $7.6 Million in 2018 to $62.3 Million in 2021. “Today’s recognition by The Globe and Mail, one of Canada’s most prestigious daily newspapers, is further validation of Delta 9’s continued growth trajectory,” said John Arbuthnot, CEO of Delta 9. “We achieved significant revenue growth over the last 3 years by...

NEW YORK, NY, Sept. 23, 2022 (GLOBE NEWSWIRE) — Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ:GFAI, GFAIW), an integrated security solutions provider, announced today that it has entered into a partnership agreement with Riversoft Inc. (“Riversoft”), a Peakwork Company who is specialized in travel management software, to co-develop and co-launch contactless travel services with its existing GFAI’s Concierge robots. Guardforce AI and Riversoft plan to co-develop these contactless travel services in a new robotic solution to be known as Robot Travel Agency (“RTA”). The RTA will be an e-commerce portal where travelers can purchase itineraries, transportation, accommodations, tours and more. The RTA platform will be linked to Riversoft’s’ booking engine which connects to major travel suppliers for hotel booking,...

Combined Products Enable Minimally-Invasive, High Precision Laser Focal Therapy of Prostate Tumors in an Office or Clinic LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) — CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, and Focalyx Technologies, developer of image-guided fusion target devices, today announced the companies will exhibit and demonstrate their respective TRANBERG™ Thermal Therapy System for focal laser ablation and Focalyx® Fusion medical device at the FOCAL 2022 Conference being held September 22-24, 2022 in Los Angeles. The conference theme is, ”Frontiers in Oncologic Prostate Care and Ablative Local Therapy.” The TRANBERG™ System is designed to work with multiple MR/US fusion image guidance systems for precise and accurate tumor ablation in a minimally invasive, outpatient setting. Compared to other...

NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Matthew Davis, its Chief Medical Officer, purchased 75,000 common shares at $0.83 per share, bringing his total holding to 175,000 common shares. About Tiziana Life SciencesTiziana Life Sciences is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable alternative routes of immunotherapy. Tiziana’s innovative nasal, oral and inhalation approaches in development have the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery. Tiziana’s...